Reversal of T-cell Tolerance in Myelodysplastic Syndrome through Lenalidomide Immune Modulation

समान संसाधन

• Immune dysregulation in myelodysplastic syndrome
  द्वारा: Sugimori, Chiharu, और अन्य
  प्रकाशित: (2010)
• Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies
  द्वारा: McDaniel, Jessica M., और अन्य
  प्रकाशित: (2012)
• Telomere length in myelodysplastic syndromes
  द्वारा: Rollison, Dana E., और अन्य
  प्रकाशित: (2011)
• A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction
  द्वारा: Komrokji, Rami S., और अन्य
  प्रकाशित: (2014)
• Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion
  द्वारा: Duong, Vu H., और अन्य
  प्रकाशित: (2012)